Torrent Pharmaceuticals Ltd (TORNTPHARM):企業の財務・戦略的SWOT分析

【英語タイトル】Torrent Pharmaceuticals Ltd (TORNTPHARM) - Financial and Strategic SWOT Analysis Review

GlobalDataが出版した調査資料(DATA904C4824)・商品コード:DATA904C4824
・発行会社(調査会社):GlobalData
・発行日:2018年8月
・ページ数:45
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Torrent Pharmaceuticals Ltd (TORNTPHARM) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Torrent Pharmaceuticals Ltd (Torrent) manufactures and markets branded and unbranded generic pharmaceuticals. It provides products in cardiovascular, central nervous system, gastro-intestinal, diabetology, anti-infective and pain management segments. Also, the company has presence in nephrology, cancer, gynecology and pediatric segments. Torrent has a fully equipped research center that is approved by the US FDA and various other regulatory authorities and manufacturing facilities at Indrad, Baddi, Sikkim, Dahej and Pithampur. The company has presence in more than forty countries worldwide and has wholly owned subsidiaries in USA, the UK, Germany, Russia, Brazil, Mexico, Philippines and other major markets. Torrent is headquartered in Ahmedabad, Gujarat, India.

Torrent Pharmaceuticals Ltd Key Recent Developments

Jul 26,2018: Torrent Pharmaceuticals: Intimation of cessation of director of the company
Dec 11,2017: Torrent & Novo Nordisk India expand insulin manufacturing facility at Indrad
Jul 31,2017: Torrent Pharma announces Q1 FY 2017-18 Results
Jul 22,2017: Torrent Pharmaceuticals : Intimation of Resignation of Director of the Company
May 26,2017: Torrent Pharmaceuticals Reports Revenue Of INR19.8 Billion In Fiscal 2017

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Torrent Pharmaceuticals Ltd – Key Facts 5
Torrent Pharmaceuticals Ltd – Key Employees 6
Torrent Pharmaceuticals Ltd – Key Employee Biographies 7
Torrent Pharmaceuticals Ltd – Major Products and Services 8
Torrent Pharmaceuticals Ltd – History 9
Torrent Pharmaceuticals Ltd – Locations And Subsidiaries 11
Head Office 11
Other Locations & Subsidiaries 11
Section 2 – Company Analysis 14
Company Overview 14
Torrent Pharmaceuticals Ltd – Business Description 15
Torrent Pharmaceuticals Ltd – Corporate Strategy 16
Torrent Pharmaceuticals Ltd – SWOT Analysis 17
SWOT Analysis – Overview 17
Torrent Pharmaceuticals Ltd – Strengths 17
Torrent Pharmaceuticals Ltd – Weaknesses 18
Torrent Pharmaceuticals Ltd – Opportunities 19
Torrent Pharmaceuticals Ltd – Threats 20
Torrent Pharmaceuticals Ltd – Key Competitors 21
Section 3 – Company Financial Ratios 22
Financial Ratios – Capital Market Ratios 22
Financial Ratios – Annual Ratios 23
Performance Chart 26
Financial Performance 26
Financial Ratios – Interim Ratios 27
Financial Ratios – Ratio Charts 28
Section 4 – Company’s Lifesciences Financial Deals and Alliances 29
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30
Torrent Pharmaceuticals Ltd, Recent Deals Summary 31
Section 5 – Company’s Recent Developments 32
Jul 26, 2018: Torrent Pharmaceuticals: Intimation of cessation of director of the company 32
Dec 11, 2017: Torrent & Novo Nordisk India expand insulin manufacturing facility at Indrad 33
Dec 11, 2017: Torrent & Novo Nordisk India expand insulin manufacturing facility at Indrad 35
Jul 31, 2017: Torrent Pharma announces Q1 FY 2017-18 Results 37
Jul 22, 2017: Torrent Pharmaceuticals : Intimation of Resignation of Director of the Company 39
May 26, 2017: Torrent Pharmaceuticals Reports Revenue Of INR19.8 Billion In Fiscal 2017 40
Section 6 – Appendix 41
Methodology 41
Ratio Definitions 41
About GlobalData 45
Contact Us 45
Disclaimer 45

List of Tables
Torrent Pharmaceuticals Ltd, Key Facts 5
Torrent Pharmaceuticals Ltd, Key Employees 6
Torrent Pharmaceuticals Ltd, Key Employee Biographies 7
Torrent Pharmaceuticals Ltd, Major Products and Services 8
Torrent Pharmaceuticals Ltd, History 9
Torrent Pharmaceuticals Ltd, Other Locations 11
Torrent Pharmaceuticals Ltd, Subsidiaries 11
Torrent Pharmaceuticals Ltd, Key Competitors 21
Torrent Pharmaceuticals Ltd, Ratios based on current share price 22
Torrent Pharmaceuticals Ltd, Annual Ratios 23
Torrent Pharmaceuticals Ltd, Annual Ratios (Cont...1) 24
Torrent Pharmaceuticals Ltd, Annual Ratios (Cont...2) 25
Torrent Pharmaceuticals Ltd, Interim Ratios 27
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30
Torrent Pharmaceuticals Ltd, Recent Deals Summary 31
Currency Codes 41
Capital Market Ratios 41
Equity Ratios 42
Profitability Ratios 42
Cost Ratios 43
Liquidity Ratios 43
Leverage Ratios 44
Efficiency Ratios 44

List of Figures
Torrent Pharmaceuticals Ltd, Performance Chart (2014 - 2018) 26
Torrent Pharmaceuticals Ltd, Ratio Charts 28
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 30

★調査レポート[Torrent Pharmaceuticals Ltd (TORNTPHARM):企業の財務・戦略的SWOT分析] (コード:DATA904C4824)販売に関する免責事項を必ずご確認ください。
★調査レポート[Torrent Pharmaceuticals Ltd (TORNTPHARM):企業の財務・戦略的SWOT分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆